Literature DB >> 17273829

Commentary on "Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic review".

Blanca E Del-Rio-Navarro1, Virginia Blandon-Vigil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17273829     DOI： 10.1007/s00431-007-0420-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  Compilation and meta-analysis of randomized placebo-controlled clinical trials on the prevention of respiratory tract infections in children using immunostimulants.

Authors:  A Berber; B Del-Rio-Navarro
Journal:  J Investig Allergol Clin Immunol       Date:  2001       Impact factor: 4.333

Review 2.  Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review.

Authors:  Claudia Steurer-Stey; Leonie Lagler; Daniel A Straub; Johann Steurer; Lucas M Bachmann
Journal:  Eur J Pediatr       Date:  2006-11-18       Impact factor: 3.183

Review 3.  Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.

Authors:  Claire Arandjus; Peter N Black; Phillippa J Poole; Richard Wood Baker; Claudia Steurer-Stey
Journal:  Respir Med       Date:  2006-10       Impact factor: 3.415

Review 4.  Immunostimulants for preventing respiratory tract infection in children.

Authors:  B E Del-Rio-Navarro; F Espinosa Rosales; V Flenady; J J L Sienra-Monge
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  [Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico].

Authors:  Carlos de la Torre González; Aarón Pacheco Ríos; Alberto José Escalante Domínguez; Blanca Estela del Río Navarro
Journal:  Rev Alerg Mex       Date:  2005 Jan-Feb

Review 6.  Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review.

Authors:  Claudia Steurer-Stey; Lucas M Bachmann; Johann Steurer; Martin R Tramèr
Journal:  Chest       Date:  2004-11       Impact factor: 9.410
  6 in total
  3 in total

1.  Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome.

Authors:  D Alecsandru; L Valor; S Sánchez-Ramón; J Gil; J Carbone; J Navarro; J Rodríguez; C Rodríguez-Sainz; E Fernández-Cruz
Journal:  Clin Exp Immunol       Date:  2011-04       Impact factor: 4.330

2.  Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway.

Authors:  Carmen Parola; Laura Salogni; Xenia Vaira; Sara Scutera; Paolo Somma; Valentina Salvi; Tiziana Musso; Giuseppe Tabbia; Marco Bardessono; Christian Pasquali; Alberto Mantovani; Silvano Sozzani; Daniela Bosisio
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

3.  Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art.

Authors:  Fernando De Benedetto; Gianfranco Sevieri
Journal:  Multidiscip Respir Med       Date:  2013-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.